Additionally, if gastrointestinal side effects persist beyond the first 8-12 weeks of treatment or worsen over time rather than improving, discuss this with your provider, as it may indicate the need for alternative treatment approaches
Chance Miller, underscores our commitment to tailored care in achieving successful outcomes
So she, you call that amenorrhea, but she described it as, I hit menopause way too early. She didnt have her period for 10 years
ELI LILLY'S ORAL GLP-1 THERAPY FOUNDAYO (ORFORGLIPRON) IS NOW AVAILABLE FOR WEIGHT LOSS April 2026 Foundayo is the second oral GLP-1 drug approved for weight management The issue: GLP-1 weight-loss therapies are the most talked-about drug class ever Why this matters: In January 2026, Wegovy tablets became the first oral GLP-1 drug approved for weight loss
Movement might make you feel worse
Side effects Most common: nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, fatigue, and injection-site reactions